By Ralph Nader / Common DreamsJan 2, 2016
With press report after press report documenting how big business stiffs millions of its consumers and workers, why is it that more of these victims do not externalize some of their inner agonies by channeling them into civic outrage? Dig deeper ( 4 Min. Read )
Robert Reich / TruthdigDec 22, 2015
The former hedge-fund manager and pharmaceutical executive may be a rotten apple, but hedge funds and the pharmaceutical industry are two rotten systems that are costing Americans a bundle. Dig deeper ( 4 Min. Read )
Staff / TruthdigOct 21, 2015
A bill that would speed up approval for medications and medical devices shows how a major initiative can get traction even in the midst of Washington gridlock — but critics say all the lobbying is drowning out some warnings about patient safety. Dig deeper ( 10 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Kasia Anderson / TruthdigOct 7, 2015
Some are bound to chalk this news up to the magical equalizing powers of capitalism’s famous "invisible hand," while others might point to the democratizing sting of actual journalism as the more potent force in this mix. Dig deeper ( 2 Min. Read )
Kasia Anderson / TruthdigOct 5, 2015
Another drug company has joined the likes of the recently exposed Turing Pharmaceuticals by jacking up prices of life-sustaining meds on extremely short notice. Remember this name: Valeant Pharmaceuticals International. Dig deeper ( 1 Min. Read )
Staff / TruthdigSep 24, 2015
If you have a tattoo, you no longer have to worry about it dying out with your body, thanks to a new service; a piece explains why we're unable to keep pharmaceutical companies from charging absurd amounts for drugs; meanwhile, a year after the Ayotzinapa disappearances in Mexico, relatives of the missing students are still seeking justice. These discoveries and more after the jump. Dig deeper ( 2 Min. Read )
Roisin Davis / TruthdigSep 23, 2015
Pharmaceuticals CEO Martin Shkreli is being called the most hated man in America for raising the price of the HIV drug Daraprim from $13.50 to $750 per pill. Now his earlier pricing decisions are being examined. It is being reported that one such decision led to a 2,000 percent price increase for a medication taken by children suffering from a rare kidney disease. Dig deeper ( 2 Min. Read )
Staff / TruthdigSep 23, 2015
In case you hadn't heard, last month, Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli got hold of the rights to parasite-zapping drug Daraprim, and then he had the bright idea to raise the price from $13.50 to $750 per pill. Now he has a big public relations problem and a self-created health care crisis on his hands. Dig deeper ( 1 Min. Read )
Staff / TruthdigSep 4, 2015
Large numbers of people with learning disabilities and no record of severe mental illness are being prescribed strong psychotropic drugs, possibly as a means of subduing and controlling uncooperative patients, research shows. Dig deeper ( 2 Min. Read )
By Ralph NaderJun 9, 2015
"We have an opportunity to set the most progressive trade agreement in our nation's history," reads BarackObama.com, the website of the president's "Organizing for Action" campaign. Dig deeper ( 5 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.